During late tumorigenesis, heterogeneous cancer-associated fibroblasts (CAFs) were identified in mouse models of breast cancer, including a population of CD34– myofibroblastic CAFs (myCAFs) that were transcriptionally and phenotypically similar to senescent CAFs. The gene discussed is CD34; the disease is breast carcinoma.